{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:10:12Z","timestamp":1778605812566,"version":"3.51.4"},"reference-count":18,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background:\u00a0Candida isolation is common in critically ill patients, but its clinical interpretation depends strongly on microbiological source, host factors, and clinical context. Bloodstream isolation, candiduria, respiratory tract isolation, surveillance cultures, catheter-tip cultures, and wound\/skin cultures have different clinical implications. We aimed to evaluate clinical characteristics, microbiological sources, species distribution, antifungal treatment patterns, and outcomes among adult ICU patients with Candida-positive ICU cultures. Methods: This single-center retrospective observational cohort study was conducted in the medical intensive care unit of Marmara University Faculty of Medicine between 1 October 2022 and 5 September 2025. Adult ICU patients with at least one Candida-positive ICU culture were included. Non-Candida fungal isolates and duplicate patient-level records were excluded. The primary outcome was all-cause 28-day mortality. ICU mortality was defined as all-cause death during ICU stay. Source-stratified analyses and expanded multivariable logistic regression models were performed to evaluate factors associated with mortality. Results: A total of 349 adult ICU patients were included. Median age was 71 years [IQR, 62\u201382], and 185 patients were male (53.0%). Overall, 28-day mortality was 59.0% (206\/349), and ICU mortality was 65.9% (230\/349). Candida colonization was identified in 247 patients (70.8%), whereas Candida infection was identified in 102 patients (29.2%). The most common species were Candida albicans (48.4%), Candida glabrata (13.8%), and Candida auris (12.9%). The most frequent microbiological sources were urine (42.4%), lower respiratory tract samples (26.4%), and blood cultures (14.9%). Blood\/sterile-site isolation was associated with higher ICU mortality than non-blood\/non-sterile-site isolation (79.2% vs. 63.5%, p = 0.026), whereas the difference in 28-day mortality was not statistically significant (66.0% vs. 57.8%, p = 0.260). Antifungal treatment was more frequent among patients with blood\/sterile-site isolation (94.3% vs. 16.9%, p &lt; 0.001). In the expanded 28-day mortality model, lactate, NLR, and carbapenem exposure were independently associated with mortality. In the expanded ICU mortality model, lactate and CRRT\/hemodialysis were independently associated with mortality. Candida score was not independently associated with either 28-day mortality or ICU mortality after broader adjustment. Conclusions:Candida-positive ICU cultures represent a heterogeneous clinical and microbiological spectrum. Source-specific interpretation is essential, particularly when distinguishing bloodstream or sterile-site isolation from non-sterile-site colonization. Candida score may reflect a higher-risk clinical phenotype, but it should not be interpreted as a stand-alone mortality prediction tool.<\/jats:p>","DOI":"10.3390\/jcm15103710","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:04:36Z","timestamp":1778601876000},"page":"3710","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics, Microbiological Sources, and Outcomes of Candida-Positive ICU Cultures in Critically Ill Adults"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1293-3719","authenticated-orcid":false,"given":"Erdem","family":"Yal\u00e7\u0131nkaya","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-9872","authenticated-orcid":false,"given":"Umut Sabri","family":"Kasapo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-2527","authenticated-orcid":false,"given":"H\u00fcseyin","family":"Ar\u0131kan","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"\u00c7akmak","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eimal Beril","family":"Babao\u011flu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilge","family":"\u0130nce","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilanur","family":"Salta","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep G\u00f6k\u015fin","family":"Canbir","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semiha Emel","family":"Ery\u00fcksel","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6699-5798","authenticated-orcid":false,"given":"Sait","family":"Karakurt","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Marmara University School of Medicine, Istanbul 34854, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Azim, A., and Ahmed, A. (2024). Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: A comprehensive review. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1256158"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis","volume":"161","author":"Schlattmann","year":"2022","journal-title":"Chest"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3390\/molecules19011085","article-title":"Invasive fungal infections in the ICU: How to approach, how to treat","volume":"19","author":"Paramythiotou","year":"2014","journal-title":"Molecules"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and outcome of invasive candidiasis in intensive care units in Europe: Results of the EUCANDICU project","volume":"23","author":"Bassetti","year":"2019","journal-title":"Crit. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/0885066618767835","article-title":"Invasive Candidiasis in Critically Ill Patients: A Prospective Cohort Study in Two Tertiary Care Centers","volume":"35","author":"Sakkijha","year":"2020","journal-title":"J. Intensive Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive fungal diseases in adult patients in intensive care unit FUNDICU 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Saavedra","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: The EMPIRICUS randomized clinical trial","volume":"316","author":"Timsit","year":"2016","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ahmad, S., and Alfouzan, W. (2021). Candida auris: Epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms, 9.","DOI":"10.3390\/microorganisms9040807"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2019.08.013","article-title":"Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting","volume":"54","author":"Kenters","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ku, T.S.N., Walraven, C.J., and Lee, S.A. (2018). Candida auris: Disinfectants and implications for infection control. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00726"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijid.2020.10.092","article-title":"Candida colonization as a predictor of invasive candidiasis in non-neutropenic ICU patients with sepsis: A systematic review and meta-analysis","volume":"102","author":"Alenazy","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Poissy, J., Rouz\u00e9, A., Cornu, M., Nseir, S., and Sendid, B. (2022). The changing landscape of invasive fungal infections in ICUs: A need for risk stratification to better target antifungal drugs and the threat of resistance. J. Fungi, 8.","DOI":"10.3390\/jof8090946"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e25-00003","DOI":"10.1097\/JTCCM-D-25-00003","article-title":"Candida auris in intensive care unit: A growing clinical concern","volume":"7","author":"Bassetti","year":"2025","journal-title":"J. Transl. Crit. Care Med."},{"key":"ref_16","unstructured":"World Health Organization (2022). WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, World Health Organization."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12941-022-00538-y","article-title":"Incidence, clinical characteristics, risk factors and outcomes of patients with mixed Candida\/bacterial bloodstream infections: A retrospective study","volume":"21","author":"Zhong","year":"2022","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jac\/dkt099","article-title":"Mixed bloodstream infections involving bacteria and Candida spp","volume":"68","author":"Bouza","year":"2013","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3710\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:27:42Z","timestamp":1778603262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcm15103710"],"URL":"https:\/\/doi.org\/10.3390\/jcm15103710","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}